Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 16, 2019Aratana Reports Voting Results from 2019 Special Meeting of Stockholders
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting...
-
Jun 11, 2019Commercial availability of NOCITA 10 mL vial size anticipated by fall 2019
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the U.S. Food...
-
Jun 7, 2019Stockholders Elect All Class III Directors and Approve Proposals
Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, today announced the voting...
-
May 8, 2019Continued revenue growth across portfolio of marketed pet therapeutics
Aratana recorded $7.4 million in total revenues for the first quarter of 2019, including $2.5 million in NOCITA net product sales, $1.5 million in ENTYCE net product sales and $3.4 million in licensing and collaboration revenue from Elanco for GALLIPRANT.
-
May 7, 2019
The Company plans on presenting at the Stifel Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New York City.
-
Apr 26, 2019Elanco announces formation of commercial team dedicated to veterinary specialty business
The Company announced it has signed an agreement to be acquired by Elanco Animal Health (NYSE: ELAN), its global collaboration partner on GALLIPRANT® (grapiprant tablets). In conjunction with the transaction, Elanco also announced the formation of a commercial team dedicated to the veterinary specialty business. If the proposed agreement is consummated, the Aratana field force would transition into this commercial team.
-
Mar 12, 2019
The Company announced its fourth quarter and full year 2018 financial results and recent business highlights.
-
Feb 13, 2019
The Company plans on attending several upcoming investment conferences, including Bank of America Merrill Lynch Animal Health Summit, Cowen Health Care Conference and Barclays Global Healthcare Conference.
-
Feb 12, 2019
The Company will host a live conference call on Tuesday, March 12, 2019 at 4:30 p.m. ET to discuss financial results from the fourth quarter and full year ended December 31, 2018.
-
Feb 4, 2019
The Company announced the appointment of Rhonda Hellums as Chief Financial Officer and Treasurer of Aratana effective February 1, 2019.